Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Supira Medical’s Next Generation Percutaneous Ventricular Assist Device ...
Supira Medical announces first in-human use of pVAD
Supira Medical on LinkedIn: #pvad #innovation #medtech # ...
Supira Medical to initiate US clinical programme for pVAD system
Two exciting milestones to celebrate here at Supira Medical : FDA ...
Supira Medical raises $120M, completes EFS for FDA approval | Picard ...
Supira gets FDA green light - Start Medical Product Development
Supira Medical: Heart Pumps – The Next Generation - YouTube
Supira Medical Raises $120M and Completes SUPPORT I Study
Supira Medical | Success Your Apron Order Has Been Submitted
Early Experience With the Supira Microaxial Flow Pump
SUPIRA MEDICAL ANNOUNCES SUCCESSFUL FIRST-IN-HUMAN USE OF ITS NEXT ...
Supira Medical's FDA Trial Approval Marks a Crucial Step for Heart Care ...
TCT 2024 Insights: Safety and Feasibility of the Supira System in High ...
Supira Medical - 2025 Funding Rounds & List of Investors - Tracxn
Supira Medical Receives FDA Approval for SUPPORT II Pivotal Trial of ...
前沿资讯| Supira Medical pVAD系统获FDA突破性器械认证 - 上海昕诺医学研究有限公司
Results from the Early Human Experience with the Supira Percutaneous ...
Supira begins early feasibility study for percutaneous ventricular ...
Supira Medical 宣佈 SUPPORT II 關鍵性試驗獲 FDA 批准，並在心源性休克領域取得進展，同時委任 D. Keith ...
Supira Medical nets $120m to advance ventricular support device ...
Supira Medical's Percutaneous Ventricular Assist Device (pVAD) to be ...
New funding to support expansion of clinical programme for Supira ...
Exciting Day today as we are unveiling Supira Medical technology via ...
Supira Medical – 415 Capital
Supira Medical raises $120M to develop catheter-based ventricular heart ...
Shifamed Creation Supira Medical Launches With $15.5 Million Series A - WSJ
The Supira Medical team is incredibly proud of the excellent progress ...
Supira Medical’s pVAD Receives FDA Breakthrough Device Designation ...
Supira Medical Secures $120 M in Oversubscribed Series E Financing to ...
SUPIRA SYSTEM, THE NEXT GEN pVAD - YouTube
Supira Medical Challenges Heart Pump Market with FDA Trial Approval ...
Supira Medical Initiates U.S. Early Feasibility Study (EFS) for High ...
Wow! Supira Medical Series D news displayed on Nasdaq Tower in Time ...
Supira Medical, Inc. - 2025/03/26 | Piper Sandler
Supira Medical Names Dr. Azeem Latib as Medical Director - Cardiac ...
SUPIRA MEDICAL, INC., A SHIFAMED PORTFOLIO COMPANY, RECEIVES FDA ...
Supira Medical Raises $120M in Series E Financing Round for pVAD ...
#supiramedical #innovation #medicaltechnology | Supira Medical
Los Gatos California based Supira Medical is raising $30,000,000.00 in ...
FDA Approval for SUPPORT II Pivotal Trial and New Board Member | Supira ...
Supira Medical Closes $120M Series E Funding, Wraps Up SUPPORT I Early ...
How Supira Medical CEO de-risks and executes MedTech innovations ...
Supira Medical, A Shifamed Portfolio Company, Closes $35M In Series B ...
Nitin Salunke's Path from Biomechanics to Leading Supira Medical
Supira Medical’s $120 Million Series E Financing Round – Global Legal ...
Supira Medical posted on LinkedIn
Great to see Supira Medical out and about proving that their innovation ...
Invest and Sell Supira Medical Stock - Forge
Supira Medical on LinkedIn: #pcr2024 #pci #pvad #innovation #medtech # ...
Sidley represented Supira Medical, a clinical-stage Shifamed portfolio ...
The Supira Medical team is proud to celebrate the contributions of ...
Supira Medical Closes $35M in Series B Financing - G-MedTech News Center
Dr. Kandzari to present 30-day results of Supira System | Supira ...
Supira Medical、SUPPORT IIピボタル試験のFDA承認、心原性ショック分野での進展、およびD. Keith ...
Supira Medical | LinkedIn
Supira Medical on LinkedIn: #solaci2024 #pvad #hrpci #cardiovascular # ...
Supira Medical oznamuje schválení klíčové studie SUPPORT II ze strany ...
Supira Medical on LinkedIn: #livecase #tct2024 #pvad #innovation # ...
Azeem Latib joins Supira Medical as medical director
Supira Medical on LinkedIn: #supiramedical #innovation # ...
Supira Medical on LinkedIn: #europcr #pvad #innovation #medtech # ...
Supira Medical on LinkedIn: The Supira Medical team is incredibly proud ...
Supira Medical is greatly benefitting from Shifamed model. Stay tuned ...
企業情報 - Supira
Supira Medical on LinkedIn: The Launch of PA MedTech VC Fund II
Muskan Sachdeva - Process Development Engineer at Supira Medical | The Org
De-Risk and Execute to Create Value: Interview with Supira Medical CEO ...
Compass highlights: Supira Medical, Evident Vascular, VQ Biomedical ...
Next-Generation Temporary Mechanical Circulatory Support for High-Risk ...
February 28 2022
Remarkable milestone as we treated Cardiogenic Shock patients using ...
Mechanical circulatory support for complex, high-risk percutaneous ...
Shifamed
SCAI: First-in-Human Trial of a Novel Percutaneous Ventricular Assist ...
Supira’s SUPPORT II Pivotal Trial of pVAD System Approved by FDA ...
E轮融资超8亿，Supira介入式心脏泵加速临床试验进程_腾讯新闻
临床阶段心脏循环支持医疗设备开发公司：Supira Medical, Inc. | 美股之家 - 港股美股开户投资百科全书
pVAD进展：Supira小型泵首例人体应用，Impella拓展心源性休克适应症_腾讯新闻
E轮融资超8亿，Supira介入式心脏泵加速临床试验进程医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
New Heart Pump Challenges J&J's Impella
#supiramedical #innovation #medicaltechnology #makingadifference # ...
Dr. Tai Pham from UC Davis Health shared a challenging case ...
DR. AZEEM LATIB, WORLD-RENOWNED INTERVENTIONAL CARDIOLOGIST, TO JOIN ...
血管介入械企：2.86亿融资+FDA突破性器械认定_搜狐网
#losgatos #supiramedical #funding #clinicalprogram #investors #expand # ...
心闻5分钟丨健世科技Ken-Valve、埃普特医疗消融导管获批上市、雅培Volt 脉冲场消融获CE认证；多款器械进入创新通道…… - 知乎
血管介入械企：2.86亿融资+FDA突破性器械认定
Ambra Health Partners With Perspectum - G-MedTech News Center
